700 patients110,866 observations180 daysLIVE

Patient P-02502

Synthetic patientMETA-24 · Day 173 · 65–74 · M · baseline S02Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
4%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S02

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability-24
  • Inflammatory activity-11
  • Nutritional resilience+10
  • Treatment adherence+7
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    67 min
    worsening · -3.4 vs previous 14 d
    Sleep duration
    Wearable
    8.8 h
    stable · +0.0 vs previous 14 d
    Energy level
    Daily log
    7.4/10
    stable · +0.2 vs previous 14 d
    Steps
    Wearable
    7,086
    worsening · -392 vs previous 14 d
    GI burden
    Companion
    7.6/100
    worsening · +1.8 vs previous 14 d
    Adherence
    Companion
    94.7 %
    stable · +1.2 vs previous 14 d
    Sleep quality
    Wearable
    79.7/100
    stable · +1.1 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    110 mg/dL
    stable · +0.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 98 from the failing basin, 13 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +9.6
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -5.2 next day
    Main detractors to watch
    • Poor metabolizer
      hidden · steering -12.7
    • Caffeine
      perturbation · steering -11.5
    • FUT2 non-secretor
      hidden · steering -10.6
    • Histamine load
      perturbation · steering -10.6
    • Caffeine
      detractor · GI +6.4 next day
    • Histamine load
      detractor · GI +5.8 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Caffeine
      +6.4detractor · 95%
    • Histamine load
      +5.8detractor · 95%
    • Protein
      -5.2supporter · 95%
    • Simple carbohydrates
      +1.6no signal · 22%
    • Ultra-processed food
      -1.4no signal · 28%
    • Dietary fat load
      -1no signal · 23%
    • Insoluble fibre
      +0.8no signal · 16%
    • Alcohol
      -0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Drug metabolism and exposure 40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Mucosal barrier integrity 30
      • DNAFUT2 non-secretor lowers mucosal fucosylation
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 4.3 · butyrate capacity 64/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    56 ms
    Sleep
    8.2 h
    Steps
    6,728
    Resting HR
    58 bpm
    Daily log: GI score 8, nutritional resilience 73, adherence 95.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0267765%S0279
    P-0251057%S0278
    P-0241955%S1582
    P-0221254%S1784
    P-0236454%S1983
    P-0248654%S10ME-01improved86
    P-0255554%S01AD-05no change79
    P-0268854%S0988
    P-0227053%S1986
    P-0227753%S05AD-05improved92
    P-0259753%S1779
    P-0201252%S1591